Dr. Majhail will focus on the continued expansion of the Sarah Cannon Transplant and Cellular Therapy Network Centers of Excellence providing...

119 Abstracts and Presentations Featuring Sarah Cannon’s Clinical Research and Care Insights

Leading clinical researchers, academic institutions, healthcare provider organizations, patient advocacy groups, and innovative companies collaborating...

Addition of Zangmeister Cancer Center Expands Cancer Research Collaboration with American Oncology Network & Sarah Cannon Research Institute

Partnership to Advance Comprehensive Cancer Programs for Patients Across Southwestern Virginia

Daiichi Sankyo and Sarah Cannon Research Institute announced that the first patient has been dosed in the first-in-human phase 1 study evaluating...

The consortium of prominent public and private research institutions will use HCA Healthcare’s vast data on COVID-19 hospital care to improve...

In her new role, Dr. Johnson will lead the lung cancer clinical trial portfolio across the Sarah Cannon network.

Sarah Cannon announced that 53 abstracts and presentations authored by Sarah Cannon experts have been selected for presentation at the upcoming...

American Oncology Network, LLC (AON) and Sarah Cannon Research Institute announced today the addition of AON partner practice Messino Cancer ...

The trusted cancer experts at Mission Health join HCA Healthcare’s Cancer Institute to enhance cancer services for patients across western North...

Advocacy Champions are ASCO volunteers who have made meaningful contributions to ASCO’s advocacy activities throughout the year to ensure that...

This partnership brings together Lyell’s research and development of cell-based immunotherapies and Sarah Cannon’s expertise in designing and...

Through the partnership, AON and Sarah Cannon will offer clinical trial options to patients across several locations within AON’s network of ...

More Than 110 Abstracts and Presentations will be Presented by Sarah Cannon Researchers; Dr. Howard A. “Skip” Burris III Serves as ASCO® President...

The first patient has been dosed in a first-in-human phase 1 study evaluating DS-6157, an investigational GPR20 directed antibody drug conjugate...

Recovered COVID-19 patients can donate plasma to potentially help critically-ill patients

The first patient has been dosed in a first-in-human phase 1/2 study evaluating DS-7300, an investigational B7-H3 targeting antibody drug conjugate...

NASHVILLE, TENN., May 30, 2019 – Today, Sarah Cannon announced that it will present its latest cancer research insights through more than 100...

Patients in Europe Now Have Access to Cutting-Edge Immunotherapy in Phase II Clinical Trial

NASHVILLE, TENN., June 1, 2018 – Sarah Cannon announced today the appointment of three new research faculty to its drug development programs ...

Collaboration between Early Phase Research Leader, Sarah Cannon Research Institute and the NCI-Designated Sidney Kimmel Cancer Center – Jefferson...

NASHVILLE, TENN., May 31, 2018 – Today, Sarah Cannon announced that it will present its latest cancer research insights through more than 85 ...

NASHVILLE, TENN., May 30, 2018 – Today, Sarah Cannon announced the promotion of William Donnellan, MD, to Director of Leukemia/Myelodysplastic...

• New collaboration aims to further accelerate the delivery of novel treatments for multiple difficult-to-treat cancers • Collaboration will ...

NASHVILLE, Tenn., February 21, 2018 - Today, Sarah Cannon, the Cancer Institute of HCA Healthcare, announced that 18 abstracts authored by members...

Dr. Amita Patnaik and Dr. Kyriakos Papadopoulos Appointed Co-Directors of Clinical Research

Today, Sarah Cannon announced the promotion of Johanna C. Bendell, MD, to Chief Development Officer.

Sarah Cannon, the Cancer Institute of HCA Healthcare, announced today that several of its affiliated programs will participate in a new study...

Sarah Cannon to Present Latest in Blood Cancer Research at the 59th Annual American Society of Hematology Meeting

90+ presentations underscore Sarah Cannon’s expertise in drug development

Leading Provider of Cloud-based Genomics Technology Joins HCA's Global Cancer Institute to Grow Reach in Precision Medicine for People Facing...

Molecular Information-based Collaboration Focuses on Integrating Comprehensive Genomic Profiling into Clinical Trials to Enable Patient Access...

$12 million research project aimed at demonstrating the quality assurance of oncology nurse navigation to improve care and outcomes

Joint clinical development will study the combination of two checkpoint inhibitors from Boehringer Ingelheim's growing immune-oncology pipeline